SPC411
Efgartigimod alfa
Status:
VeittApplication date:
18.11.2022Application published:
15.12.2022Grant published:
15.9.2024
Max expiry date:
10.8.2037Medicine name:
VyvgartMedicine for children:
No
Timeline
Today
18.11.2022Application
15.12.2022Publication
15.9.2024Registration
10.8.2037Expires
Marketing license
IS authorization number:
EU/1/22/1674Date:
17.8.2022
Foreign authorization number:
EU/1/22/1674Date:
10.8.2022
Owner
Name:
argenx BVAddress:
Industriepark 7, Zwijnaarde BE
Name:
The Board of Regents of The University of Texas SystemAddress:
210 West 7th Street, Austin US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP3087095
Deadlines
TypeDeadline until
Type: Frestur til að fara yfir drög að vottorði
Deadline until: 16.09.2024